v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Equity Award Plan
Common Stock
Common Stock
Equity Award Plan
Additional Paid-In Capital
Additional Paid-In Capital
Equity Award Plan
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023     46,723,143          
Beginning balance at Dec. 31, 2023 $ 248,670   $ 5   $ 803,260   $ (556,239) $ 1,644
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with equity award plans (in shares)       337,963        
Issuance of common stock in connection with equity award plans   $ 1,205       $ 1,205    
Stock-based compensation 11,664       11,664      
Net loss (25,279)           (25,279)  
Other comprehensive income (loss) (1,657)             (1,657)
Ending balance (in shares) at Mar. 31, 2024     47,061,106          
Ending balance at Mar. 31, 2024 234,603   $ 5   816,129   (581,518) (13)
Beginning balance (in shares) at Dec. 31, 2024     48,338,096          
Beginning balance at Dec. 31, 2024 $ 225,640   $ 5   870,189   (644,181) (373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with equity award plans (in shares)       1,112,939        
Issuance of common stock in connection with equity award plans   $ 6,359       $ 6,359    
Conversion of convertible notes, net (in shares) 188              
Conversion of convertible notes, net $ 6              
Stock-based compensation 15,813       15,813      
Net loss (14,677)           (14,677)  
Other comprehensive income (loss) 115             115
Ending balance (in shares) at Mar. 31, 2025     49,451,223          
Ending balance at Mar. 31, 2025 $ 233,256   $ 5   $ 892,367   $ (658,858) $ (258)